NCCN Guidelines for Patients® | Diffuse Large B-cell Lymphoma – For Patients | – For Clinicians NCCN Foundation ® gratefully acknowledges our Industry supporters AbbVie Inc. and Gilead Sciences Inc. for their support in making available these NCCN Guidelines for Patients ® . NCCN independently develops and distributes the NCCN Guidelines for Patients. Our industry supporters do not participate in the development of the NCCN Guidelines for Patients and are not responsible for the content and recommendations contained therein. PAT-N-1015-0917 275 Commerce Drive Suite 300 Fort Washington, PA 19034 215.690.0300 NCCN GUIDELINES FOR PATIENTS ® Diffuse Large B-cell Lymphoma 2017